BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kanda M, Sugimoto H, Kodera Y. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma. World J Gastroenterol 2015; 21(37): 10584-10597 [PMID: 26457018 DOI: 10.3748/wjg.v21.i37.10584]
URL: https://www.wjgnet.com/1007-9327/full/v21/i37/10584.htm
Number Citing Articles
1
Jing Wang, Shuzhi Wu, Tianren Huang. Expression and role of VEGFA and miR‑381 in portal vein tumor thrombi in patients with hepatocellular carcinomaExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.6129
2
Britta Laube, Sandra Michaelsen, Veronika Meischner, Andrea Hartwig, Bernd Epe, Michael Schwarz. Classification or non-classification of substances with positive tumor findings in animal studies: Guidance by the German MAK commissionRegulatory Toxicology and Pharmacology 2019; 108: 104444 doi: 10.1016/j.yrtph.2019.104444
3
Yan-Yan Jia, Jin-Yi Zhao, Bing-Ling Li, Kai Gao, Ying Song, Mei-You Liu, Xiao-Juan Yang, Yan Xue, Ai-Dong Wen, Lei Shi. miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growthOncotarget 2016; 7(23): 35257 doi: 10.18632/oncotarget.9135
4
Meng Pu, Jianlin Wang, Qike Huang, Ge Zhao, Congcong Xia, Runze Shang, Zhuochao Zhang, Zhenyuan Bian, Xishegn Yang, Kaishan Tao. High MRPS23 expression contributes to hepatocellular carcinoma proliferation and indicates poor survival outcomesTumor Biology 2017; 39(7): 101042831770912 doi: 10.1177/1010428317709127
5
Guadalupe S. López-Álvarez, Tomasz K. Wojdacz, Claudia M. García-Cuellar, Hugo C. Monroy-Ramírez, Miguel A. Rodríguez Segura, Ruth A. Pacheco Rivera, Carlos A. Valencia-Antúnez, Nancy C. Cervantes-Anaya, Ernesto Soto-Reyes, Verónica R. Vázquez-Garzón, Yesennia Sánchez-Pérez, Saúl Villa Treviño. Gene silencing of Nox4 by CpG island methylation during hepatocarcinogenesis in ratsBiology Open 2016;  doi: 10.1242/bio.020370
6
Dai Shimizu, Mitsuro Kanda, Hiroyuki Sugimoto, Masahiro Shibata, Haruyoshi Tanaka, Hideki Takami, Naoki Iwata, Masamichi Hayashi, Chie Tanaka, Daisuke Kobayashi, Suguru Yamada, Goro Nakayama, Masahiko Koike, Michitaka Fujiwara, Tsutomu Fujii, Yasuhiro Kodera. The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomyInternational Journal of Oncology 2017; 50(2): 381 doi: 10.3892/ijo.2017.3833
7
Xiaoming Liu, Xingyu Chen, Mengqing Xiao, Yuxing Zhu, Renjie Gong, Jianye Liu, Qinghai Zeng, Canxia Xu, Xiong Chen, Fen Wang, Ke Cao. RANBP2 Activates O-GlcNAcylation through Inducing CEBPα-Dependent OGA Downregulation to Promote Hepatocellular Carcinoma Malignant PhenotypesCancers 2021; 13(14): 3475 doi: 10.3390/cancers13143475
8
Chieh-Hsiang Chan, Chun-Ming Chen, Yan-Hwa Wu Lee, Li-Ru You. DNA Damage, Liver Injury, and Tumorigenesis: Consequences of DDX3X LossMolecular Cancer Research 2019; 17(2): 555 doi: 10.1158/1541-7786.MCR-18-0551
9
Xin Qing, Wenjing Xu, Jingjing Zong, Xuanlong Du, Hao Peng, Yewei Zhang. Emerging treatment modalities for systemic therapy in hepatocellular carcinomaBiomarker Research 2021; 9(1) doi: 10.1186/s40364-021-00319-3
10
Mitsuro Kanda, Yasuhiro Kodera. Molecular mechanisms of peritoneal dissemination in gastric cancerWorld Journal of Gastroenterology 2016; 22(30): 6829-6840 doi: 10.3748/wjg.v22.i30.6829
11
Aimei Liu, Qinghua Wu, Dapeng Peng, Irma Ares, Arturo Anadón, Bernardo Lopez‐Torres, María‐Rosa Martínez‐Larrañaga, Xu Wang, María‐Aránzazu Martínez. A novel strategy for the diagnosis, prognosis, treatment, and chemoresistance of hepatocellular carcinoma: DNA methylationMedicinal Research Reviews 2020; 40(5): 1973 doi: 10.1002/med.21696
12
Yonghao Liang, Qisheng Li, Keli Chen, Wen Ni, Zetao Zhan, Feng Ye, Yiyi Li, Yuan Fang, Fengjiao Zhang, Longhua Chen, Yi Ding. Zinc finger protein 307 functions as a tumor-suppressor and inhibits cell proliferation by inducing apoptosis in hepatocellular carcinomaOncology Reports 2017; 38(4): 2229 doi: 10.3892/or.2017.5868
13
Lili Cao, Lijun Zhang, Xiang Zhao, Ye Zhang, Daolin Tang. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma CellsPLOS ONE 2016; 11(8): e0161025 doi: 10.1371/journal.pone.0161025
14
Shinichi Umeda, Mitsuro Kanda, Yasuhiro Kodera. Recent advances in molecular biomarkers for patients with hepatocellular carcinomaExpert Review of Molecular Diagnostics 2019; 19(8): 725 doi: 10.1080/14737159.2019.1638254
15
Xiu-Yan Huang, Zi-Li Huang, Yong-Hua Xu, Qi Zheng, Zi Chen, Wei Song, Jian Zhou, Zhao-You Tang, Xin-Yu Huang. Comprehensive circular RNA profiling reveals the regulatory role of the circRNA-100338/miR-141-3p pathway in hepatitis B-related hepatocellular carcinomaScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-05432-8
16
Satoko Umetsu, Hiroki Mizukami, Takeshi Saito, Chiaki Uchida, Akiko Igawa, Kazuhiro Kudo, Chieko Itabashi, Sho Osonoi, Guo Danyang, Takanori Sasaki, Soroku Yagihashi, Kenichi Hakamada. Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylationScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-57883-1
17
Jia-Cheng Tang, Yi-Li Feng, Tao Guo, An-Yong Xie, Xiu-Jun Cai. Circulating tumor DNA in hepatocellular carcinoma: trends and challengesCell & Bioscience 2016; 6(1) doi: 10.1186/s13578-016-0100-z
18
Ci Song, Yao Liu, Lu Xu, Juan Wen, Deke Jiang, Jianguo Chen, Xiangjun Zhai, Zhibin Hu, Li Liu, Jibin Liu. Hepatitis B virus mutations, expression quantitative trait loci for PTPN 12, and their interactions in hepatocellular carcinoma Cancer Medicine 2016; 5(7): 1687 doi: 10.1002/cam4.712
19
Yue-Li Nan, Yan-Ling Hu, Zhi-Ke Liu, Fang-Fang Duan, Yang Xu, Shu Li, Ting Li, Da-Fang Chen, Xiao-Yun Zeng. Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinomaWorld Journal of Gastroenterology 2016; 22(24): 5558-5567 doi: 10.3748/wjg.v22.i24.5558
20
Chinthalapally V. Rao, Adam S. Asch, Hiroshi Y. Yamada. Frequently mutated genes/pathways and genomic instability as prevention targets in liver cancerCarcinogenesis 2017; 38(1): 2 doi: 10.1093/carcin/bgw118
21
Nadia Panera, Annalisa Crudele, Ilaria Romito, Daniela Gnani, Anna Alisi. Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2017; 18(1): 99 doi: 10.3390/ijms18010099
22
Qin Tang, Qi Wang, Qiong Zhang, Sheng-Yan Lin, Yanhong Zhu, Xiangliang Yang, An-Yuan Guo. Gene expression, regulation of DEN and HBx induced HCC mice models and comparisons of tumor, para-tumor and normal tissuesBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3860-x
23
Man Wu, Xueqing Xia, Jiemiao Hu, Natalie Wall Fowlkes, Shulin Li. WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expressionNature Communications 2021; 12(1) doi: 10.1038/s41467-021-23864-9
24
Leilei Niu, Liping Liu, Shengli Yang, Jianwei Ren, Paul B.S. Lai, George G. Chen. New insights into sorafenib resistance in hepatocellular carcinoma: Responsible mechanisms and promising strategiesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2017; 1868(2): 564 doi: 10.1016/j.bbcan.2017.10.002
25
Shinichi Umeda, Mitsuro Kanda, Hiroyuki Sugimoto, Haruyoshi Tanaka, Masamichi Hayashi, Suguru Yamada, Tsutomu Fujii, Hideki Takami, Yukiko Niwa, Naoki Iwata, Chie Tanaka, Daisuke Kobayashi, Michitaka Fujiwara, Yasuhiro Kodera. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinomaBMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3629-2
26
Yan Wang, Mengjing Sun, Jibin Liu, Ying Liu, Chunyi Jiang, Huijun Zhu, Wei Wang, Yao Wang. FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinomaOncology Letters 2019;  doi: 10.3892/ol.2019.11183
27
Xiaolong Liu, Xiaotong Hu, Yeye Kuang, Peijian Yan, Lili Li, Chen Li, Qian Tao, Xiujun Cai. BCLB, methylated in hepatocellular carcinoma, is a starvation stress sensor that induces apoptosis and autophagy through the AMPK-mTOR signaling cascadeCancer Letters 2017; 395: 63 doi: 10.1016/j.canlet.2017.02.030
28
Mitsuro Kanda, Dai Shimizu, Haruyoshi Tanaka, Masahiro Shibata, Naoki Iwata, Masamichi Hayashi, Daisuke Kobayashi, Chie Tanaka, Suguru Yamada, Tsutomu Fujii, Goro Nakayama, Hiroyuki Sugimoto, Masahiko Koike, Michitaka Fujiwara, Yasuhiro Kodera. Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancerOncotarget 2016; 7(12): 13667 doi: 10.18632/oncotarget.7269
29
Jonathan Choiniere, Jianguo Wu, Li Wang. Pyruvate Dehydrogenase Kinase 4 Deficiency Results in Expedited Cellular Proliferation through E2F1-Mediated Increase of CyclinsMolecular Pharmacology 2017; 91(3): 189 doi: 10.1124/mol.116.106757
30
Nan Cheng, Ju Wu, Min Yin, Jian Xu, Yadong Wang, Xi Chen, Zhequn Nie, Jiajun Yin. LncRNA CASC11 promotes cancer cell proliferation in hepatocellular carcinoma by inhibiting miRNA-188-5pBioscience Reports 2019; 39(4) doi: 10.1042/BSR20190251
31
Mitsuro Kanda, Kenta Murotani, Hiroyuki Sugimoto, Takashi Miwa, Shinichi Umeda, Masaya Suenaga, Masamichi Hayashi, Norifumi Hattori, Chie Tanaka, Daisuke Kobayashi, Suguru Yamada, Michitaka Fujiwara, Yasuhiro Kodera. An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinomaOncotarget 2017; 8(41): 71070 doi: 10.18632/oncotarget.20369
32
Fang Wang, Peter Breslin S J, Wei Qiu. Novel oncogenes and tumor suppressor genes in hepatocellular carcinomaLiver Research 2021;  doi: 10.1016/j.livres.2021.06.001
33
Bolin Wu, Xitian Liang, Hui Jing, Xue Han, Yixin Sun, Cunli Guo, Ying Liu, Wen Cheng. Effect of NET-1 siRNA conjugated sub-micron bubble complex combined with low-frequency ultrasound exposure in gene transfectionOncotarget 2018; 9(3): 4150 doi: 10.18632/oncotarget.23646
34
Fu-Biao Ni, Zhuo Lin, Xu-Hui Fan, Ke-Qing Shi, Jian-Yang Ao, Xiao-Dong Wang, Rui-Cong Chen. A novel genomic-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinomaClinica Chimica Acta 2020; 504: 88 doi: 10.1016/j.cca.2020.02.001
35
Yuting Wu, Yingshi Zhang, Xiaochun Qin, Haobin Geng, Daiying Zuo, Qingchun Zhao. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinomaPharmacological Research 2020; 160: 105195 doi: 10.1016/j.phrs.2020.105195
36
Cheng Guo, Jie Zhou, Boyu Ma, Rui Wang, Yanli Ge, Zhe Wang, Bing Ji, Wei Wang, Junjie Zhang, Zhirong Wang. A Somatic Mutation-Derived LncRNA Signature of Genomic Instability Predicts Prognosis for Patients With Liver CancerFrontiers in Surgery 2021; 8 doi: 10.3389/fsurg.2021.724792
37
Zhiyu Ye, Xudong Chen, Xiaogang Chen. ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transitionOncology Letters 2017;  doi: 10.3892/ol.2017.7453